Compare AbCellera Biologics Inc (ABCL) vs DraftKings Inc (DKNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs DraftKings Inc — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while DraftKings Inc trades at $25.23 (market cap $12.58B). The key difference: DraftKings Inc is far larger — about 4.2× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | DKNG | |
|---|---|---|
Market Cap | $2.99B | $12.58B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $48.23 |
52-Week Low | $2.78 | $20.72 |
Enterprise Value | $2.58B | $13.51B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About DraftKings Inc
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →
